DISSOLUTION MEDIUM - A CRITICAL PARAMETER TO IDENTIFY BIOAVAILABILITY PROBLEMS OF FUROSEMIDE TABLETS

被引:15
作者
PRASAD, VK
RAPAKA, RS
KNIGHT, PW
CABANA, BE
机构
关键词
D O I
10.1016/0378-5173(82)90180-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:81 / 90
页数:10
相关论文
共 15 条
[1]   SOME PHYSICO-CHEMICAL FACTORS IN DRUG ACTION [J].
BRODIE, BB ;
HOGBEN, CAM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1957, 9 (06) :345-380
[2]   GASTRO-INTESTINAL SITES OF FUROSEMIDE ABSORPTION IN RATS [J].
CHUNGI, VS ;
DITTERT, LW ;
SMITH, RB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1979, 4 (01) :27-38
[3]  
HAJDU P, 1964, Arzneimittelforschung, V14, P709
[4]   CLINICAL PHARMACOLOGY OF FUROSEMIDE AND ETHACRYNIC ACID [J].
KIRKENDALL, WM ;
STEIN, JH .
AMERICAN JOURNAL OF CARDIOLOGY, 1968, 22 (02) :162-+
[5]  
MARSHALL K, 1979, MODERN PHARMACEUTICS, P368
[6]  
MARTIN BK, UNPUB J PHARM SCI
[8]   INVIVO EVALUATION OF EFFECT OF 5 DISINTEGRANTS ON BIOAVAILABILITY OF FRUSEMIDE FROM 40MG-TABLETS [J].
RUBINSTEIN, MH ;
PRICE, EJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 :P5-P5
[9]   EFFECT OF 4 TABLET BINDERS ON THE BIOAVAILABILITY OF FRUSEMIDE FROM 40MG TABLETS [J].
RUBINSTEIN, MH ;
RUGHANI, JM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1978, 4 (06) :541-553
[10]   FUROSEMIDE - A CLINICAL EVALUATION OF ITS DIURETIC ACTION [J].
STASON, WB ;
CANNON, PJ ;
HEINEMANN, HO ;
LARAGH, JH .
CIRCULATION, 1966, 34 (05) :910-+